Search Results
Aug 26, 2026, 09:00 ET Benchmark Gensuite Chem Agent Wins 2026 OH&S New Product of the Year
OH&S New Product of the Year awards reinforce what we believe enterprise AI must deliver: practical value in the workflows that matter every day," said R. Mukund, CEO of Benchmark Gensuite. "The Chem Agent takes on the document-intensive work behind chemical safety and SDS compliance so EHS professionals
More news about: Benchmark Gensuite
Aug 26, 2026, 09:00 ET ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease
year."People living with CMT, particularly children, urgently need more effective disease-modifying treatment options," said Paul R. August, Ph.D., Chief Scientific Officer of ReviR Therapeutics. "This designation provides additional support for the continued development of RTX-117.
More news about: ReviR Therapeutics
Aug 26, 2026, 09:00 ET JACKSON AND CHARVEL DEBUT SLEEP TOKEN SIGNATURE GUITAR AND BASS
redefines what heavy music can sound like. The band shatters genre boundaries, fusing djent-weighted riffs, cinematic pop atmospheres and haunting R&B textures into a sound that feels both intimate and colossal. Drawn to that same boundary-pushing spirit, Jackson and Charvel capture it in two new
More news about: Fender Musical Instruments Corporation
Aug 26, 2026, 08:31 ET Odevo Appoints Steve Nylund as U.S. CEO
https://news.cision.com/odevo-ab/r/odevo-appoints-steve-nylund-as-u-s--ceo,c4388118The following files are available for download:
More news about: Odevo AB
Aug 26, 2026, 08:30 ET FibroBiologics Regains Compliance with Nasdaq Trading Rules
its business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics' R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; (d) the ability of FibroBiologics to successfully prosecute
More news about: FibroBiologics, Inc.
Aug 26, 2026, 08:30 ET Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
times above expectations, this expansion was key in ramping capacity to meet demand as we anticipate reaching unconstrained levels in early 2027. Our R&D and manufacturing engine is stronger than ever to deliver a consistent flow of high impact innovation to meet higher pet owner expectation of care
More news about: Elanco Animal Health
Aug 26, 2026, 08:30 ET Leifras Anticipates Benefit from Expanded Trading Access as Nasdaq Plans 23-Hour Weekday Trading
https://www.nikkei.com/article/DGXZQOUB31B9X0R30C26A7000000/[5] Source:
More news about: LEIFRAS Co., Ltd.
Aug 26, 2026, 08:13 ET E&R Engineering presenta nuevas soluciones de perforación láser y plasma híbrido en SEMICON Taiwan 2026
plasma principales de E&REl PHB-600A está diseñado para paneles de vidrio de gran formato y procesamiento láser de alta precisión, y cumple con los requisitos avanzados de empaquetado para áreas de procesamiento, alta precisión y rendimiento constante.El R-300R cuenta con un sistema
More news about: E&R Engineering Corp.
Aug 26, 2026, 08:02 ET Four Kantor & Kantor, LLP Attorneys Recognized in the 2027 Edition of The Best Lawyers in America ®
Northridge, California:Lisa S. Kantor - Insurance Law. Lisa has been recognized in Best Lawyers since 2018.Glenn R. Kantor - Employee Benefits (ERISA) Law and Litigation - ERISA. Glenn has been recognized in Best Lawyers since 2024.Martina Sherman -
More news about: Kantor & Kantor, LLP
Aug 26, 2026, 08:00 ET Ministry of Food and Drug Safety of Korea, Accelerates the Pace of Innovation for the Great Leap in Bio
authority through in-depth discussions and workshops with experts from overseas regulatory authoritiesTo create a venue for promoting the R&D achievements of Korean companies and for sharing knowledge and experience with overseas regulators and experts, thereby supporting the global expansion
More news about: The Korea Herald
Aug 26, 2026, 07:59 ET Rubenstein Law Attorneys Named to 2027 Best Lawyers® and Best Lawyers: Ones to Watch®
Peter R. Hunt - Recognized in Admiralty and Maritime Law; Personal Injury Litigation - Plaintiffs
More news about: Rubenstein Law
Aug 26, 2026, 07:18 ET Uit de studie van Zendure blijkt: Regelgeving, huurovereenkomsten en een ingewikkeld installatieproces vertragen de invoering van zonne-energie
2025.Over ZendureGedreven door ons doel om een duurzame toekomst te versnellen, is Zendure een wereldwijde pionier van plug-in HEMS. Met R&D- en operationele centra die zich uitstrekken over grote technologische centra zoals Silicon Valley en de Greater Bay Area, naast Japan en Duitsland,
More news about: Zendure
Aug 26, 2026, 07:15 ET Bluon brings back best-in-class Live Tech Support for HVAC-R field technicians
multimedia:https://www.prnewswire.com/news-releases/bluon-brings-back-best-in-class-live-tech-support-for-hvac-r-field-technicians-302859910.htmlSOURCE
More news about: Bluon
Aug 26, 2026, 07:13 ET Selon une étude de Zendure, la réglementation, les contrats de location et un processus d'installation perçu comme complexe ralentissent l'adoption de l'énergie solaire
systèmes enfichables de gestion de l'énergie domestique, animé par sa volonté d'accélérer la transition vers un avenir durable. Portée par des centres de R & D et d'exploitation répartis dans les principaux pôles technologiques tels que la Silicon Valley ou la région de la Grande Baie, ainsi qu'au Japon
More news about: Zendure
Aug 26, 2026, 07:00 ET HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
[1] Mafra A, Laversanne M, Marcos-Gragera R et al. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. J Natl Cancer Inst. 2025 May 1;117(5):907-914.
More news about: HaemaLogiX Ltd
Aug 26, 2026, 06:47 ET Alebund Pharmaceuticals Announces 2026 Interim Results
with R1 Therapeutics. In March 2026, the Company announced that it had entered into licensing and equity agreements in respect of its product candidate AP306 with R1. The Company retains all rights to AP306 in Greater China and holds an equity interest in R1 as a principal shareholder, while R1 has
More news about: Alebund Pharmaceuticals
Aug 26, 2026, 06:44 ET 禮邦醫藥發佈 2026 年中期業績
沉積。外部合作就 AP306 與 R1 Therapeutics 訂立許可與股權協議。2026 年 3 月，公司公佈就在研產品 AP306 與 R1 訂立許可與股權協議。公司保留 AP306 於大中華區的全部權利，並以主要股東身份持有 R1 股權；R1 取得於大中華區以外地區開發、生產及商業化 AP306 的獨家許可。R1 股東包括全球腎臟病護理巨頭 DaVita（NYSE：DVA）及 U.S. Renal Care。報告期內，公司就該交易確認許可收入人民幣 79.3
More news about: 禮邦醫藥
Aug 26, 2026, 06:40 ET Nematicides Market worth $5.60 billion by 2031- Exclusive Report by MarketsandMarkets™
species. Acquisitions and partnerships are also enabling companies to broaden geographic reach, accelerate product commercialization, and strengthen R&D capabilities. The growing emphasis on integrated pest management, regulatory pressure on certain chemical active ingredients, and increasing demand
More news about: MarketsandMarkets
Aug 26, 2026, 06:37 ET Commercialization Roadmap Validated with Three-digit Million-dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026
March, the Company signed a global out-licensing and R&D collaboration agreement with Lilly valued up to US$2.75 billion, including an upfront payment of US$115 million. This marks Lilly's role transformation from a platform user to an R&D partner, cornerstone investor, and ultimately an in-depth
More news about: Insilico Medicine
Aug 26, 2026, 06:15 ET RHINOSHIELD AirX entre dans l'histoire avec un GUINNESS WORLD RECORDS™ pour une chute libre depuis les portes de l'espace
dans plus de 9 langues et protégeant plus de 20 millions d'appareils à travers le monde. Grâce à ses activités de R&D et de fabrication intégrées à Taïwan, RHINOSHIELD fait progresser l'innovation dans les matériaux par le biais d'une conception circulaire et de solutions
More news about: RHINOSHIELD
Aug 26, 2026, 06:08 ET RHINOSHIELD AirX Sets GUINNESS WORLD RECORDS™ Title in Record-Breaking Near-Space Drop Challenge
footprint, engaging users across multilingual markets in over 9 languages and protecting over 20 million devices worldwide.With integrated R&D and manufacturing in Taiwan, RHINOSHIELD advances material innovation through circular design and plastic management solutions—creating high-performance
More news about: RHINOSHIELD
Aug 26, 2026, 06:00 ET Heat Pump Market worth $169.04 billion by 2031 | MarketsandMarkets™
notes that heat pump deployment in buildings is the near-term engine of global growth. The increasing adoption of low-GWP refrigerants, including R290 and R32, is further supporting product development and expanding the addressable market for air-to-water systems.The commercial segment is projected
More news about: MarketsandMarkets
Aug 26, 2026, 05:38 ET Global Times: From follower to trendsetter - How China is redefining auto industry
show, overseas buyers and media shifted their focus from curiosity about low prices to curiosity about technology. "They kept asking us how we improve R&D efficiency and whether our technologies could be licensed," a Leapmotor employee said.Joerg Wuttke, former president of the European
More news about: Global Times
Aug 26, 2026, 05:29 ET SK Biopharmaceuticals to In-License Epilepsy Drug Candidate 'Opakalim'
discovery, high-throughput organic screening/high content screening, computer-aided drug design, and combinatorial chemistry, the companies drive R&D efforts in biology/discovery, medicinal chemistry, pharmacology, and clinical development. For more information, visit
More news about: SK Biopharmaceuticals. Co., Ltd.
Aug 26, 2026, 05:00 ET Yatsen to Announce Second Quarter 2026 Financial Results on September 2, 2026
and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.For more information, please visit http://ir.yatsenglobal.com.For
More news about: Yatsen Holding Limited